Literature DB >> 17236779

Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14.

David F Wozniak1, Maolei Xiao, Lin Xu, Kelvin A Yamada, David M Ornitz.   

Abstract

Spinocerebellar ataxia 27 (SCA27) is a recently described syndrome characterized by impaired cognitive abilities and a slowly progressive ataxia. SCA27 is caused by an autosomal dominant missense mutation in Fibroblast Growth Factor 14 (FGF14). Mice lacking FGF14 (Fgf14(-/-) mice) have impaired sensorimotor functions, ataxia and paroxysmal dyskinesia, a phenotype that led to the discovery of the human mutation. Here we extend the similarities between Fgf14(-/-) mice and FGF14(F145S) humans by showing that Fgf14(-/-) mice exhibit reliable acquisition (place learning) deficits in the Morris water maze. This cognitive deficit appears to be independent of sensorimotor disturbances and relatively selective since Fgf14(-/-) mice performed similarly to wild type littermates during cued water maze trials and on conditioned fear and passive avoidance tests. Impaired theta burst initiated long-term synaptic potentiation was also found in hippocampal slices from Fgf14(-/-) mice. These results suggest a role for FGF14 in certain spatial learning functions and synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236779      PMCID: PMC2267915          DOI: 10.1016/j.nbd.2006.11.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice.

Authors:  M L Schaefer; S T Wong; D F Wozniak; L M Muglia; J A Liauw; M Zhuo; A Nardi; R E Hartman; S K Vogt; C E Luedke; D R Storm; L J Muglia
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14.

Authors:  Maolei Xiao; Lin Xu; Fernanda Laezza; Kelvin Yamada; Sheng Feng; David M Ornitz
Journal:  Mol Cell Neurosci       Date:  2007-01-08       Impact factor: 4.314

3.  Structure and expression of a novel isoform of mouse FGF homologous factor (FHF)-4.

Authors:  S Yamamoto; T Mikami; N Ohbayashi; M Ohta; N Itoh
Journal:  Biochim Biophys Acta       Date:  1998-05-29

4.  Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing.

Authors:  I Munoz-Sanjuan; P M Smallwood; J Nathans
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14.

Authors:  Q Wang; D G McEwen; D M Ornitz
Journal:  Mech Dev       Date:  2000-02       Impact factor: 1.882

6.  The role of nociceptin in cognition.

Authors:  T Nabeshima; Y Noda; T Mamiya
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

7.  Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.

Authors:  Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

8.  Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults.

Authors:  David F Wozniak; Richard E Hartman; Maureen P Boyle; Sherri K Vogt; Ashley R Brooks; Tatyana Tenkova; Chainllie Young; John W Olney; Louis J Muglia
Journal:  Neurobiol Dis       Date:  2004-12       Impact factor: 5.996

9.  Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias.

Authors:  Andreas Dalski; Jassemien Atici; Friedmar R Kreuz; Yorck Hellenbroich; Eberhard Schwinger; Christine Zühlke
Journal:  Eur J Hum Genet       Date:  2005-01       Impact factor: 4.246

10.  Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice.

Authors:  N Ho; J A Liauw; F Blaeser; F Wei; S Hanissian; L M Muglia; D F Wozniak; A Nardi; K L Arvin; D M Holtzman; D J Linden; M Zhuo; L J Muglia; T A Chatila
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.709

View more
  55 in total

1.  Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.

Authors:  Mitchell Goldfarb; Jon Schoorlemmer; Anthony Williams; Shyam Diwakar; Qing Wang; Xiao Huang; Joanna Giza; Dafna Tchetchik; Kevin Kelley; Ana Vega; Gary Matthews; Paola Rossi; David M Ornitz; Egidio D'Angelo
Journal:  Neuron       Date:  2007-08-02       Impact factor: 17.173

Review 2.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 3.  Provisional hypotheses for the molecular genetics of cognitive development: imaging genetic pathways in the anterior cingulate cortex.

Authors:  John Fossella; Jin Fan; Xun Liu; Kevin Guise; Karin Brocki; Patrick R Hof; Raja Kittappa; Ronald McKay; Michael Posner
Journal:  Biol Psychol       Date:  2007-12-28       Impact factor: 3.251

4.  Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels.

Authors:  Regina Goetz; Katarzyna Dover; Fernanda Laezza; Nataly Shtraizent; Xiao Huang; Dafna Tchetchik; Anna V Eliseenkova; Chong-Feng Xu; Thomas A Neubert; David M Ornitz; Mitchell Goldfarb; Moosa Mohammadi
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

5.  CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.

Authors:  Wei-Chun J Hsu; Federico Scala; Miroslav N Nenov; Norelle C Wildburger; Hannah Elferink; Aditya K Singh; Charles B Chesson; Tetyana Buzhdygan; Maveen Sohail; Alexander S Shavkunov; Neli I Panova; Carol L Nilsson; Jai S Rudra; Cheryl F Lichti; Fernanda Laezza
Journal:  FASEB J       Date:  2016-02-25       Impact factor: 5.191

6.  Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function.

Authors:  Liana Roberts Stein; David F Wozniak; Joshua T Dearborn; Shunsuke Kubota; Rajendra S Apte; Yukitoshi Izumi; Charles F Zorumski; Shin-ichiro Imai
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

7.  Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment.

Authors:  Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

Review 8.  Fibroblast Growth Factor Homologous Factors: New Roles in Neuronal Health and Disease.

Authors:  Juan L Pablo; Geoffrey S Pitt
Journal:  Neuroscientist       Date:  2014-12-09       Impact factor: 7.519

9.  Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring.

Authors:  M C Opazo; A Gianini; F Pancetti; G Azkcona; L Alarcón; R Lizana; V Noches; P A Gonzalez; M P Marassi; M Porto; S Mora; D Rosenthal; E Eugenin; D Naranjo; S M Bueno; A M Kalergis; C A Riedel
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

Review 10.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.